Neuburgh Advisers’s Dynavax Technologies DVAX Stock Holding History

Neuburgh Advisers’s Portfolio DVAX Stock Details DVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-4,080	Closed	-$51K	–	906
2018 Q3	$51K	Hold	4,080	–	–	﹤0.01%	853
2018 Q2	$62K	Buy	+4,080	New	+$70.5K	﹤0.01%	834

Other funds holding DVAX

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

Neuburgh Advisers's DVAX Position: Q4 2018 in Review

Neuburgh Advisers sold out of Dynavax Technologies (DVAX) in Q4 2018, closing a stake of 4,080 shares — an estimated $51K sold.

Neuburgh Advisers first reported a position in DVAX in Q2 2018 and held it in 2 quarters. The position peaked at $62K in Q2 2018. 132 funds tracked by Wall St. Rank hold DVAX as of Q4 2018.

Neuburgh Advisers reported no remaining Dynavax Technologies position as of Q4 2018 after selling out during the quarter.
Neuburgh Advisers sold 4,080 Dynavax Technologies shares in Q4 2018, an estimated $51K.
Neuburgh Advisers first reported a position in Dynavax Technologies in Q2 2018 and held it in 2 quarters.
Neuburgh Advisers's Dynavax Technologies position peaked at $62K in Q2 2018.
132 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2018.

Based on Neuburgh Advisers's 13F filing for Q4 2018, filed 13 Feb 2019.